Results

Total Results: 187 records

Showing results for "pharmacists".

  1. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/opioid-chronic-pain-surveillance-report-2.pdf
    April 01, 2022 - Canadian Pharmacists Journal 2020 Jan-Feb;153(1):52-8. doi:10.1177/1715163519887766. … Assessing the impact of clinical pharmacists on naloxone coprescribing in the primary care setting.
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/plant-based-chronic-pain-review-jan-2020.pdf
    January 01, 2020 - Journal of the American Pharmacists Association: JAPhA. 2020 Jan - Feb;60(1):225-34.e6. … Pharmacist. 2020;45(3):24-8. Exclusion reason: Ineligible publication type 112. Thomas J.
  3. effectivehealthcare.ahrq.gov/products/blood-clots-hip-knee-surgery/research-protocol
    August 06, 2010 - constituency of clinicians (surgeons, hematologists, hospitalists, internists, physician’s assistants, pharmacists
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-update-2015_research-protocol.pdf
    January 01, 2015 - including family practitioners, general internists, nurse practitioners, physician assistants, nurses, pharmacists
  5. effectivehealthcare.ahrq.gov/sites/default/files/vte-protocol-8-4-10.pdf
    February 01, 2008 - constituency of clinicians (surgeons, hematologists, hospitalists, internists, physician’s assistants, pharmacists
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/blood-clots-hip-knee-surgery_research-protocol.pdf
    February 01, 2008 - constituency of clinicians (surgeons, hematologists, hospitalists, internists, physician’s assistants, pharmacists
  7. effectivehealthcare.ahrq.gov/sites/default/files/Disposition%20of%20Comments.pdf
    September 03, 2019 - potential downside it presents as being a “guideline” for antipsychotics is that busy providers, pharmacists
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/Disposition%20of%20Comments.pdf
    September 03, 2019 - potential downside it presents as being a “guideline” for antipsychotics is that busy providers, pharmacists
  9. effectivehealthcare.ahrq.gov/products/palliative-care-integration/protocol
    January 10, 2020 - educational materials; Guidelines and position statements Society of Pain and Palliative Care Pharmacists
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/delirium-disposition-comments.pdf
    September 03, 2019 - potential downside it presents as being a “guideline” for antipsychotics is that busy providers, pharmacists
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/palliative-care-research-amended-protocol.pdf
    November 21, 2019 - and educational materials; Guidelines and position statements Society of Pain and Palliative Care Pharmacists
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-failure-transition-care_disposition-comments.pdf
    May 27, 2014 - Pharmacists are not clinicians but are considered providers. … of “clinician” is used; some consider this to be any provider (e.g., nurse, psychologist, doctor, pharmacist … section, we define home-visit (i.e., a visit to the patient’s home by a provider, usually a nurse or pharmacist
  13. effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1406.pdf
    June 01, 2014 - available for consultation; case managers, physician extenders, occupational and physical therapists, and pharmacists … patients of the hospital’s geriatric ED “were prescribed five or more medications, and through the pharmacist
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/peripheral-artery-disease-treatment_disposition-comments.pdf
    May 29, 2013 - nonprofit medical society comprised of physicians, nurses, nurse practitioners, physician assistants, pharmacists
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioid-chronic-pain-surveillance-report-3.pdf
    June 01, 2022 - Evaluation of a pharmacist-led naloxone coprescribing program in primary care. … Patient acceptance of naloxone resulting from targeted intervention from community pharmacists to prevent … Assessing the impact of clinical pharmacists on naloxone coprescribing in the primary care setting.
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/payer-usability_white-paper.pdf
    February 01, 2014 - number of other users of evidence within their organizations who might offer useful input, including pharmacists
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/allergy-seasonal_executive.pdf
    July 01, 2013 - Key Informants were patients, providers (allergists, a pediatric pulmonologist, pharmacists, otorhinolaryngologists
  18. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/opioid-chronic-pain-surveillance-report-3.pdf
    June 01, 2022 - Evaluation of a pharmacist-led naloxone coprescribing program in primary care. … Patient acceptance of naloxone resulting from targeted intervention from community pharmacists to prevent … Assessing the impact of clinical pharmacists on naloxone coprescribing in the primary care setting.
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-map-hcbs-draft-technical-brief.pdf
    December 07, 2023 - The collaborative models included various healthcare professionals, including physicians, nurses, pharmacists … Impact of a pharmacist-physician collaborative care model on patient outcomes and health services utilization
  20. effectivehealthcare.ahrq.gov/products/heart-failure-transition-care/research-protocol
    June 10, 2013 - Does the effectiveness of interventions differ based on delivery personnel (e.g., nurse, pharmacist)?

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: